Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Thomas Hedner, Sverre E. Kjeldsen, Krzysztof Narkiewicz & Suzanne Oparil. (2016) The polypill: an emerging treatment alternative for secondary prevention of cardiovascular disease. Blood Pressure 25:5, pages 276-279.
Read now
Read now
Niki Katsiki, Vasilios G. Athyros & Asterios Karagiannis. (2013) Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?. Journal of Drug Assessment 2:1, pages 67-71.
Read now
Read now
Marios Margaritis & Charalambos Antoniades. (2012) Statins in coronary artery bypass grafting surgery: lipid lowering and beyond. Expert Review of Cardiovascular Therapy 10:1, pages 5-8.
Read now
Read now
Articles from other publishers (31)
Lilian Grigorian-Shamagian, Antonio Coca, Joao Morais, Pablo Perez-Martinez, Adriana Barragan, Ana Isabel Barrientos, Alexandre Amaral e Silva, Akhmetzhan Sugraliyev, Alexander Parkhomenko, Álvaro Sosa Liprandi, Biljana Parapid, Carlos Olivares, Carlos Ignacio Ponte Negretti, Daniel Quesada, Dragana Kosevic, Edith Ruiz Gastelum, Emilio Samael Peralta López, Francisco Araujo, Francisco Gerardo Padilla Padilla, François Krzesinski, Imad Alhaddad, Jose Alejandro Chavez Fernandez, Jose R. Gonzalez-Juanatey, M. Samir Arnaout, Mar Castellanos, Maxima Mendez, Monica Acevedo, Olena Koval, Pablo Jorge, Parounak Zelveian, Reinhold Kreutz & Vira Tseluyko. (2023) The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report. BMC Proceedings 17:S8.
Crossref
Crossref
Patrick Despang, Martin Schikora & Wolfram Doehner. (2023) „Polypill“ in der kardiovaskulären Prävention – erfolgreich durch Vereinfachung?The polypill in cardiovascular prevention: successful through simplification?. Die Innere Medizin 64:6, pages 598-604.
Crossref
Crossref
Gerard Sotorra-Figuerola, Dan Ouchi, Ana García-Sangenís, Maria Giner-Soriano & Rosa Morros. (2022) Pharmacological treatment after acute coronary syndrome: Baseline clinical characteristics and gender differences in a population-based cohort study. Atención Primaria 54:1, pages 102157.
Crossref
Crossref
Gerard Sotorra‐Figuerola, Dan Ouchi, Maria Giner‐Soriano & Rosa Morros. (2021)
Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population‐based cohort study.
IMPACT
study
. Pharmacoepidemiology and Drug Safety 30:9, pages 1250-1257.
Crossref
Crossref
Tian-Tian Ma, Ian C. K. Wong, Kenneth K. C. Man, Yang Chen, Thomas Crake, Muhiddin A. Ozkor, Ling-Qing Ding, Zi-Xuan Wang, Lin Zhang & Li Wei. (2019) Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis. PLOS ONE 14:1, pages e0210988.
Crossref
Crossref
Jakub Gawrys, Karolina Gawrys, Ewa Szahidewicz-Krupska, Arkadiusz Derkacz, Jakub Mochol & Adrian Doroszko. (2018) Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Min Li, Chengyu Li, Shiqi Chen, Yang Sun, Jiayuan Hu, Chen Zhao, Ruijin Qiu, Xiaoyu Zhang, Qin Zhang, Guihua Tian & Hongcai Shang. (2018) Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology 9.
Crossref
Crossref
Christopher P. Jackman, Asvin M. Ganapathi, Huda Asfour, Ying Qian, Brian W. Allen, Yanzhen Li & Nenad Bursac. (2018) Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation. Biomaterials 159, pages 48-58.
Crossref
Crossref
Valentín Fuster, Francesc Gambús, Aldo Patriciello, Margaretha Hamrin & Diederick E. Grobbee. (2017) The polypill approach – An innovative strategy to improve cardiovascular health in Europe. BMC Pharmacology and Toxicology 18:1.
Crossref
Crossref
C. Barth, S. Diekmann, S. Neusser, P. Bramlage, J. Wasem & A. Neumann. (2017) Polypille in der Sekundärprävention des HerzinfarktesPolypill for secondary prevention of myocardial infarction. Der Kardiologe 11:6, pages 473-479.
Crossref
Crossref
Mikhail V. Blagosklonny. (2017) From rapalogs to anti-aging formula. Oncotarget 8:22, pages 35492-35507.
Crossref
Crossref
José Ramón González-Juanatey, José María Mostaza, José María Lobos, Benjamín Abarca, José Luis Llisterri, Gonzalo Baron-Esquivias, Enrique Galve, Rosa María Lidón, Francisco Xavier Garcia-Moll, Pedro Luis Sánchez, Carmen Suárez, Jesús Millán, Vicente Pallares, José Juan Alemán & Isabel Egocheaga. (2017) Documento de consenso del uso clínico de la Polypill en la prevención secundaria del riesgo cardiovascular. Medicina Clínica 148:3, pages 139.e1-139.e15.
Crossref
Crossref
José Ramón González-Juanatey, José María Mostaza, José María Lobos, Benjamín Abarca, José Luis Llisterri, Gonzalo Baron-Esquivias, Enrique Galve, Rosa María Lidón, Francisco Xavier Garcia-Moll, Pedro Luis Sánchez, Carmen Suárez, Jesús Millán, Vicente Pallares, José Juan Alemán & Isabel Egocheaga. (2017) Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease. Medicina Clínica (English Edition) 148:3, pages 139.e1-139.e15.
Crossref
Crossref
Vivencio Barrios, Lisette Kaskens, José María Castellano, Juan Cosin-Sales, José Emilio Ruiz, Ilonka Zsolt, Valentín Fuster & Alfredo Gracia. (2017) Utilidad de un policomprimido cardiovascular en el tratamiento de pacientes en prevención secundaria en España: un estudio de coste-efectividad. Revista Española de Cardiología 70:1, pages 42-49.
Crossref
Crossref
Vivencio Barrios, Lisette Kaskens, José María Castellano, Juan Cosin-Sales, José Emilio Ruiz, Ilonka Zsolt, Valentín Fuster & Alfredo Gracia. (2017) Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study. Revista Española de Cardiología (English Edition) 70:1, pages 42-49.
Crossref
Crossref
Nursen Keles, Yusuf Yilmaz & Mustafa Caliskan. 2017. Resistant Hypertension in Chronic Kidney Disease. Resistant Hypertension in Chronic Kidney Disease
233
257
.
Elizabeth A. Chrischilles, Kathleen M. Schneider, Mary C. Schroeder, Elena Letuchy, Robert B. Wallace, Jennifer G. Robinson & John M. Brooks. (2016) Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction. Journal of the American Geriatrics Society 64:3, pages 526-535.
Crossref
Crossref
Ignacio Ferreira-González, Xavier Carrillo, Victoria Martín, José M. de la Torre Hernández, José Antonio Baz, Josep Navarro Manchón, Mónica Masotti, Ángel Cequier, Mérida Cárdenas & Fernando Alfonso Manterola. (2016) Variabilidad interhospitalaria en la prescripción tras un síndrome coronario agudo: hallazgos del estudio ACDC. Revista Española de Cardiología 69:2, pages 117-124.
Crossref
Crossref
Ignacio Ferreira-González, Xavier Carrillo, Victoria Martín, José M. de la Torre Hernández, José Antonio Baz, Josep Navarro Manchón, Mónica Masotti, Ángel Cequier, Mérida Cárdenas & Fernando Alfonso Manterola. (2016) Interhospital Variability in Drug Prescription After Acute Coronary Syndrome: Insights From the ACDC Study. Revista Española de Cardiología (English Edition) 69:2, pages 117-124.
Crossref
Crossref
Rafaela Batista dos Santos Pedrosa & Roberta Cunha Matheus Rodrigues. (2016) Adaptation and evaluation of the measurement properties of the Brazilian version of the Self-efficacy for Appropriate Medication Adherence Scale. Revista Latino-Americana de Enfermagem 24:0.
Crossref
Crossref
V. Becerra, A. Gracia, K. Desai, S. Abogunrin, S. Brand, R. Chapman, F. Garcia Alonso, V. Fuster & G. Sanz. (2015) Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK. BMJ Open 5:5, pages e007111-e007111.
Crossref
Crossref
Domingo Orozco-Beltrán, Concepción Carratalá-Munuera & Vicente Gil-Guillén. (2015) Mejorar la adherencia: una de las acciones más eficientes para aumentar la supervivencia de los pacientes en prevención secundaria. Revista Española de Cardiología Suplementos 15, pages 12-18.
Crossref
Crossref
Ginés Sanz, José M. Castellano & Valentín Fuster. (2014) Policomprimido: ¿quimera o realidad?. Revista Española de Cardiología 67:9, pages 689-692.
Crossref
Crossref
Ginés Sanz, José M. Castellano & Valentín Fuster. (2014) Polypill: Chimera or Reality?. Revista Española de Cardiología (English Edition) 67:9, pages 689-692.
Crossref
Crossref
Ute Amann, Inge Kirchberger, Margit Heier, Hildegard Golüke, Wolfgang von Scheidt, Bernhard Kuch, Annette Peters & Christa Meisinger. (2014) Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry. Clinical Research in Cardiology.
Crossref
Crossref
Renee Stark, Inge Kirchberger, Matthias Hunger, Margit Heier, Reiner Leidl, Wolfgang von Scheidt, Christa Meisinger & Rolf Holle. (2013) Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines. Clinical Research in Cardiology 103:3, pages 237-245.
Crossref
Crossref
Felipe de los Ríos la Rosa & Joseph P. Broderick. (2013) Toward a Modern Delivery of Stroke Care in Emerging Economies. Journal of Stroke and Cerebrovascular Diseases 22:7, pages e1-e3.
Crossref
Crossref
Anthony S Gunnell, Kristjana Einarsdóttir, Frank Sanfilippo, Danny Liew, C D'Arcy J Holman & Tom Briffa. (2013) Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study. Heart 99:18, pages 1353-1358.
Crossref
Crossref
Melvin Lafeber, Wilko Spiering, Yolanda van der Graaf, Hendrik Nathoe, Michiel L. Bots, Diederick E. Grobbee & Frank L.J. Visseren. (2013) The combined use of aspirin, a statin, and blood pressure–lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease. American Heart Journal 166:2, pages 282-289.e1.
Crossref
Crossref
Alexander Zhavoronkov, Edouard Debonneuil, Nawazish Mirza & Igor Artyuhov. (2012) Evaluating the impact of recent advances in biomedical sciences and the possible mortality decreases on the future of health care and Social Security in the United States. Pensions: An International Journal 17:4, pages 241-251.
Crossref
Crossref
Marios Margaritis, Keith M Channon & Charalambos Antoniades. (2012) Statins and vein graft failure in coronary bypass surgery. Current Opinion in Pharmacology 12:2, pages 172-180.
Crossref
Crossref